454911319
13 Jul 2020
India DCGI gives Nod for Restricted Emergency Use to Itolizumab for moderate to severe COVID-19 patients, India
Severity: Notice
Message: Undefined variable: region
Filename: views/login_detail_view_new_V1.php
Line Number: 393
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.